Nicole Marie Vannieuwenhoven, LPC | |
500 E Veterans St, Tomah, WI 54660-3105 | |
(608) 372-3971 | |
Not Available |
Full Name | Nicole Marie Vannieuwenhoven |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 500 E Veterans St, Tomah, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962087197 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 6205-125 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nicole Marie Vannieuwenhoven, LPC 5024 Potters Xing, Pulaski, WI 54162-9812 Ph: (715) 509-0422 | Nicole Marie Vannieuwenhoven, LPC 500 E Veterans St, Tomah, WI 54660-3105 Ph: (608) 372-3971 |
News Archive
From the detection of functional brain changes that occur during Alzheimer's Disease, a research team from the Complutense University of Madrid has located a set of biomarkers that could predict which patients with Mild Cognitive Impairment have a higher risk of developing dementia.
A study using intricate fiber dissection techniques provides new insights into the deep anatomy of the human brainstem-and helps to define "safe entry zones" for neurosurgeons performing brainstem surgery, according to a special article published in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
New results from a prospective study published in the Journal of Clinical Oncology show that patients with a body mass index (BMI) in the obese range live on average two to three months less after a pancreatic cancer diagnosis, compared with healthy weight patients, even after adjusting for factors that are known to predict survival for patients with this disease, such as age and disease stage.
Merck, known as MSD outside the United States and Canada, today announced the initiation of a clinical trial to evaluate the combination of the company's investigational anti-PD-1 immunotherapy, MK-3475, and GlaxoSmithKline's orally administered kinase inhibitor, pazopanib, in advanced renal cell carcinoma.
› Verified 2 days ago
Margaret Rose Riedl, MA Counselor Medicare: Medicare Enrolled Practice Location: 601 N Superior Ave, Tomah, WI 54660 Phone: 608-374-3853 | |
Madeline Paige Armstrong, GRADUATE LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 | |
Sharon L. Thompson, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 27374 State Highway 21, Tomah, WI 54660 Phone: 608-372-5813 Fax: 608-372-0889 | |
Ms. Kathleen R Loethen, M.S., C.R.C., L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 Fax: 608-372-1281 | |
Tara Shilts, BCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St Ste 425, Tomah, WI 54660 Phone: 608-372-3971 | |
Robin M Grosch, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 430 Julie St Ste 2, Tomah, WI 54660 Phone: 715-372-5202 Fax: 608-372-0889 | |
Timothy R Fuhrmann, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 N Superior Ave, Tomah, WI 54660 Phone: 608-374-3853 |